Tregs (CD4+CD25hiCD127lo) inhibit the anti-tumor response by producing IL-10 and expressing immune checkpoints CTLA-4 and PD-1, hence higher number of these cells in the circulation is associated with more aggressive thyroid cancer (15). The gene discussed is CD4; the disease is neoplasm.